Riemann, K.; von Ahsen, J.; Böhm, T.; Schlegel, M.; Kreuzer, M.; Fenzl, T.; Russ, H.; Parsons, C.G.; Rammes, G.
GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer’s Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation. Int. J. Mol. Sci. 2025, 26, 4167.
https://doi.org/10.3390/ijms26094167
AMA Style
Riemann K, von Ahsen J, Böhm T, Schlegel M, Kreuzer M, Fenzl T, Russ H, Parsons CG, Rammes G.
GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer’s Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation. International Journal of Molecular Sciences. 2025; 26(9):4167.
https://doi.org/10.3390/ijms26094167
Chicago/Turabian Style
Riemann, Katrin, Jeldrik von Ahsen, Tamara Böhm, Martin Schlegel, Matthias Kreuzer, Thomas Fenzl, Hermann Russ, Christopher G. Parsons, and Gerhard Rammes.
2025. "GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer’s Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation" International Journal of Molecular Sciences 26, no. 9: 4167.
https://doi.org/10.3390/ijms26094167
APA Style
Riemann, K., von Ahsen, J., Böhm, T., Schlegel, M., Kreuzer, M., Fenzl, T., Russ, H., Parsons, C. G., & Rammes, G.
(2025). GAL-201 as a Promising Amyloid-β-Targeting Small-Molecule Approach for Alzheimer’s Disease Treatment: Consistent Effects on Synaptic Plasticity, Behavior and Neuroinflammation. International Journal of Molecular Sciences, 26(9), 4167.
https://doi.org/10.3390/ijms26094167
